Спасибо, диабет! Честный рассказ о том, как я надрал зад своему диагнозу

BUYSSCHAERT Martin, Diabétologie clinique, 4^e édition, De Boeck Éditions, 2011.

MONNIER Louis, Diabétologie, Elsevier Masson, 2014.

BOUCHÉ Clara Bouché, GAUTIER Jean-François, ROMAND Dorothée, VILLEDIEU Dominique, LOUVET Hélène, L’Almanach de l’insulinothérapie fonctionnelle, Éditions scientifiques L&C, 2010.

RIGAUD Daniel, 100 Idées pour accompagner votre enfant diabétique, Éditions Tom Pousse, 2016.

Веб-сайты

www.afd.asso.fr

www.diabetesatlas.org

www.who.int/diabetes/fr

www.has-sante.fr

Публикации

Часть первая

Traité des signes des causes et de la cure des maladies aiguës et chroniques, DE CAPPADOCE Arétée.

Rapport mondial sur le diabète, OMS, avril 2016.

Atlas du diabète de la FID, 6^e édition, 2013.

«Defining and Reporting Hypoglycemia in Diabetes», American Diabetes Association, Diabetes Care

2003; 26, 1902–1912.

ELBEIN S.C., «An Update on the Genetic Basis of Type 2 Diabetes», Curr Opin Endocrinol Diab, 1998, 5, 116–125.

DEFRONZO R.A., «Lilly Lecture: The Triumvirate: ß-Cell, Muscle, Liver: Collusion Responsible for NIDDM», Diabetes, 1988, 37, 667–687.

NAUCK M.A., HOMBERGER E., SIEGEL E.G., et al., «Incretin Effects of Increasing Glucose Loads in Man Calculation from Veinous Insulin and C-Peptide Eesponses», J. Clin Enocrinol Metab, 1986; 63: 492–498.

JAMBON M., CHAPTAL J., VEDEL A., SCHAAP J., «Accidents hypoglycémiques graves par un sulfamidothiodiazol (le VK 57 ou 2254 RP)», Montpellier Médical, 1942; 22: 441–444.

DE HAES W. et al, Metformin Promotes Lifespan through Mitohormesis via the Peroxiredoxin PRDX-2, PNAS, 2014; E2501–E2509.

CONCANNON P., Rich S. S., NEPOM G.T., «Genetics of Type 1A Diabetes», N Engl J Med, 2009; 360: 1646–1654.

REDONDO M.J., JEFFREY J., FAIN P.R., et al., «Concordance for Islet Auto-Immunity among Monozygotic Twins», N Engl J Med 2008; 359: 2849–2850.

WENZLAU J.M., et al., «The Cation Efflux Transporter ZnT8 (Slc30A8) is a Major Autoantigen in Human Type 1 Diabetes», Proc Natl Acad Sci, USA, 2007; 104: 17040–17045.

REWERSM, NORRI S. J., KRETOWSKI A., «Epidemiology of Type 1 Diabetes», In: Eisenbarth GS, editor, Type 1 Diabetes: Cellular, Molecular & Clinical Immunology, 2008; www.barbaradaviscenter.org.

COOK A., «Review Series on Helminths, Immune Modulation and the Hygiene Hypothesis: How Might Infection Modulate the Onset of Type one Diabetes?», Immunology, 2009; 126: 12–17.

ZIPRIS D., «Epidemiology of Type 1 Diabetes and what Animal Models Teach us about the Role Viruses in Disease Mechanisms», Clin Immunol, 2009; 131: 11–23.

ZIPRIS, D., «The Interplay Between the Gut Microbia and The Immune System in the Mechanism of Type 1 Diabetes», Curr Opin Endocrinol Diabetes Obes, 2013, 20 (4), 265–270.

Часть вторая

«Bon Usage des dispositifs médicaux – L’autosurveillance glycémique dans le diabète de type 2: une utilisation très ciblée», avril 2011.

Cash Investigation, «Comment l’industrie nous rend accros au sucre», une enquête d’Édouard Perrin et Jean-Baptiste Renaud, 2015.

«Sucres cachés, l’overdose!», 60 millions de Consommateurs.

NIELSEN S., «Eating Disorders in Females with Type 1 Diabetes: an Update of a Meta-Analysis», European Eating Disorders Review, 2002; 10: 241–254.

TAKII M., UCHIGATA Y., NOZAKI T., NISHIKATA H., KAWAL K., KOMAKI G., IWAMOTO Y., KUBOK C., «Classification of Type 1 Diabetic Females with Bulimia Nervosa into Subgroups According to Purging Behavior», Diabetes Care 2002; 25: 1571–1575.

JONES J.M., LAWSON M.L., DANEMAN D., OLMSTED M.P., RODIN G., «Eating Disorders in Adolescent Females with and without Type 1 Diabetes: Cross Sectional Study», BMJ, 2000; 320: 1563–1566.

ENGSTRÖM I., KROON M., ARVIDSSON C.G., SEGNESTAM K., SNELLMAN K., AMAN J., «Eating Disorders in Adolescent Girls with Insulin-Dependent Diabetes Mellitus: a Population-Based Case-Control Study», Acta Poediatrica, 1999; 88: 175–180.

NIELSEN S., EMBORG C., «MOLBAK A.G., Mortality in Concurrent Type 1 Diabetes and Anorexia Nervosa”, Diabetes Care, 2002; 25: 309–312.

NICOLAU, J., et al., «Eating Disorders are Frequent among Type 2 Diabetic Patients and are Associated with Worse Metabolic and Psychological Outcomes: Results from a Cross-Sectional Study in Primary and Secondary Care Settings», Acta Diabetologica, 2015: p. 1–8.